BSE filing, BSE: 540613. Summary written from the filing by ALFA Finder's alert engine.
Gautam Exim Ltd: key numbers
- Share price
- ₹17.09
- Market cap
- ₹42.12 Cr
- Revenue (annual)
- ₹28.81 Cr
- Net profit (annual)
- ₹0.22 Cr
- P/E (TTM)
- 190.0×Sector 43.1×
- Promoter holding
- 70.89%+0.00% QoQ
- FII holding
- 0.21%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gautam Exim Ltd
All →Gautam Exim Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, as per SEBI regulations. This is a routine periodic disclosure.
Gautam Exim Management Change
Gautam Exim Limited shareholders approved the re-designation of Mr. Parmeshwar Ojha from Whole-time Director to Non-Executive Director. The change is effective from August 12, 2026.
Gautam Exim Annual General Meeting
Gautam Exim Limited conducted its 21st Annual General Meeting on September 30, 2026. Shareholders approved financial statements and the appointment of SASA & Associates as statutory auditors.
Gautam Exim Annual Report
Gautam Exim Limited submitted its Annual Report for the financial year 2025-26. The company also scheduled its 21st Annual General Meeting for September 30, 2026.
Gautam Exim Annual General Meeting
Gautam Exim Limited's board approved the FY 2025-26 Annual Report and the notice for the upcoming Annual General Meeting scheduled for September 30, 2026.
Gautam Exim Board Meeting Date
Gautam Exim Ltd has scheduled a Board meeting for August 30, 2026, to approve the Annual Report for FY 2025-26 and convene the upcoming AGM.
Other bonus issue announcements
All →Shreeji Global FMCG Bonus Issue
Shreeji Global FMCG board recommended a 1:1 bonus issue funded from securities premium, with no cash paid. Paid-up capital rises from Rs.22.76 Crore to Rs.49.92 Crore.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Anlon Technology Solutions Bonus Issue
Anlon Technology Solutions fixed 02-Nov-2026 as the record date for its 2:5 bonus issue of equity shares. The bonus is free shares from reserves, with no cash paid.
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Titan Biotech Bonus Issue
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.
Utssav CZ Gold Jewels Bonus Issue
Utssav CZ Gold Jewels' board recommended a 1:1 bonus issue from free reserves on 23 October 2026. Paid-up capital rises from Rs.25.00 Crore to Rs.50.00 Crore, subject to AGM/postal ballot on 25 November 2026.